Interactions of chlordecone (kepone) and mirex with the nicotinic acetylcholine receptor--ion channel complex.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 2422792)

Published in Toxicol Lett on March 01, 1986

Authors

R S Aronstam, J S Hong

Articles by these authors

(truncated to the top 100)

Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5. Science (1997) 14.41

Localized mutagenesis of any specific small region of the bacterial chromosome. Proc Natl Acad Sci U S A (1971) 7.98

Adenosine 3':5'-cyclic monophosphate concentration in the bacterial host regulates the viral decision between lysogeny and lysis. Proc Natl Acad Sci U S A (1971) 3.39

Regional difference in susceptibility to lipopolysaccharide-induced neurotoxicity in the rat brain: role of microglia. J Neurosci (2000) 2.75

Cloning and complete nucleotide sequence of the Escherichia coli glutamine permease operon (glnHPQ). Mol Gen Genet (1986) 2.73

Mutants of Salmonella typhimurium and Escherichia coli pleiotropically defective in active transport. Proc Natl Acad Sci U S A (1972) 2.22

Naloxone protects rat dopaminergic neurons against inflammatory damage through inhibition of microglia activation and superoxide generation. J Pharmacol Exp Ther (2000) 2.14

Requirements of acetyl phosphate for the binding protein-dependent transport systems in Escherichia coli. Proc Natl Acad Sci U S A (1979) 2.13

Brain injury in a dish: a model for reactive gliosis. Trends Neurosci (1994) 1.80

Nanometer size diesel exhaust particles are selectively toxic to dopaminergic neurons: the role of microglia, phagocytosis, and NADPH oxidase. FASEB J (2004) 1.79

An ecf mutation in Escherichia coli pleiotropically affecting energy coupling in active transport but not generation or maintenance of membrane potential. J Biol Chem (1977) 1.62

Identification and nucleotide sequence of the activator gene of the externally induced phosphoglycerate transport system of Salmonella typhimurium. Gene (1986) 1.58

Regional distribution of LEU and MET enkephalin in rat brain. Neuropharmacology (1977) 1.43

Addition of a short peptide ligand to the adenovirus fiber protein. Gene Ther (1995) 1.42

Molar extinction coefficient and iron and sulfide content of clostridial ferredoxin. J Biol Chem (1970) 1.41

Molecular consequences of activated microglia in the brain: overactivation induces apoptosis. J Neurochem (2001) 1.40

Mechanisms of active transport in isolated bacterial membrane vesicles. XII. Active transport by a mutant of Escherichia coli uncoupled for oxidative phosphorylation. Arch Biochem Biophys (1973) 1.39

The mechanism underlying cystic fibrosis transmembrane conductance regulator transport from the endoplasmic reticulum to the proteasome includes Sec61beta and a cytosolic, deglycosylated intermediary. J Biol Chem (1998) 1.39

Characterization of Escherichia coli mutant incapable of maintaining a transmembrane potential. MetC ecfts mutations. J Biol Chem (1977) 1.37

A mutant of Escherichia coli defective in the coupling of metabolic energy to active transport. Proc Natl Acad Sci U S A (1974) 1.37

Influence of sulfhydryl reagents and heavy metals on the functional state of the muscarinic acetylcholine receptor in rat brain. Mol Pharmacol (1978) 1.33

Cloning and sequencing of a gene encoding a glutamate and aspartate carrier of Escherichia coli K-12. J Bacteriol (1990) 1.32

Activation, inactivation, and desensitization of acetylcholine receptor channel complex detected by binding of perhydrohistrionicotoxin. Proc Natl Acad Sci U S A (1980) 1.28

Nucleotide sequence and transcription start point of the phosphoglycerate transporter gene of Salmonella typhimurium. J Bacteriol (1988) 1.26

Genetics of the glutamine transport system in Escherichia coli. J Bacteriol (1981) 1.22

Prognostic factors for recurrence with unilateral recess-resect procedure in patients with intermittent exotropia. Eye (Lond) (2011) 1.20

Rat striatal methionine-enkephalin content after chronic treatment with cataleptogenic and noncataleptogenic antischizophrenic drugs. J Pharmacol Exp Ther (1978) 1.17

Nucleotide sequence of the genes encoded in early region 2b of human adenovirus type 12. Gene (1986) 1.17

Integrating signals from IFN-gamma and IL-4 by B cells: positive and negative effects on CD40 ligand-induced proliferation, survival, and division-linked isotype switching to IgG1, IgE, and IgG2a. J Immunol (1999) 1.16

Identification of the products and nucleotide sequences of two regulatory genes involved in the exogenous induction of phosphoglycerate transport in Salmonella typhimurium. J Bacteriol (1988) 1.14

Reconstitution of D-lactate-dependent transport in membrane vesicles from a D-lactate dehydrogenase mutant of Escherichia coli. Proc Natl Acad Sci U S A (1973) 1.14

Systemic infusion of naloxone reduces degeneration of rat substantia nigral dopaminergic neurons induced by intranigral injection of lipopolysaccharide. J Pharmacol Exp Ther (2000) 1.14

Determination of methionine enkephalin in discrete regions of rat brain. Brain Res (1977) 1.12

Phencyclidine interactions with the ionic channel of the acetylcholine receptor and electrogenic membrane. Proc Natl Acad Sci U S A (1980) 1.11

Alterations in GABA metabolism and Met-enkephalin content in rat brain following repeated electroconvulsive shocks. J Neurochem (1978) 1.10

Sites of action of phencyclidine. II. Interaction with the ionic channel of the nicotinic receptor. Mol Pharmacol (1980) 1.09

Energization of osmotic shock-sensitive transport systems in Escherichia coli requires more than ATP. Arch Biochem Biophys (1976) 1.09

Selective blockade of NMDA-activated channel currents may be implicated in learning deficits caused by lead. FEBS Lett (1990) 1.07

Reduction by naloxone of lipopolysaccharide-induced neurotoxicity in mouse cortical neuron-glia co-cultures. Neuroscience (2000) 1.07

The effects of the HIV-1 envelope protein gp120 on the production of nitric oxide and proinflammatory cytokines in mixed glial cell cultures. Cell Immunol (1996) 1.06

X-Ray crystal structures of Candida albicans dihydrofolate reductase: high resolution ternary complexes in which the dihydronicotinamide moiety of NADPH is displaced by an inhibitor. J Med Chem (2001) 1.04

A clinical inflammatory syndrome attributable to aerosolized lipid-DNA administration in cystic fibrosis. Hum Gene Ther (2001) 1.04

The anticonvulsant MK-801 interacts with peripheral and central nicotinic acetylcholine receptor ion channels. J Pharmacol Exp Ther (1990) 1.03

Global DNA methylation profiling reveals silencing of a secreted form of Epha7 in mouse and human germinal center B-cell lymphomas. Oncogene (2007) 1.02

Synergistic neurotoxic effects of combined treatments with cytokines in murine primary mixed neuron/glia cultures. J Neuroimmunol (1998) 1.02

ATP-driven active transport in right-side-out bacterial membrane vesicles. Proc Natl Acad Sci U S A (1981) 1.02

M3 muscarinic acetylcholine receptors regulate cytoplasmic myosin by a process involving RhoA and requiring conventional protein kinase C isoforms. J Biol Chem (1999) 1.01

Changes in active transport, intracellular adenosine 5'-triphosphate levels, macromolecular syntheses, and glycolysis in an energy-uncoupled mutant of Escherichia coli. J Bacteriol (1976) 1.01

Potent regulation of microglia-derived oxidative stress and dopaminergic neuron survival: substance P vs. dynorphin. FASEB J (2006) 1.01

Influence of neurons on lipopolysaccharide-stimulated production of nitric oxide and tumor necrosis factor-alpha by cultured glia. Brain Res (2000) 1.00

Projections of substance P containing neurons from neostriatum to substantia nigra. Brain Res (1977) 1.00

Glia-dependent neurotoxicity and neuroprotection in mesencephalic cultures. Brain Res (1995) 1.00

Elevated dynorphin in the hippocampal formation of aged rats: relation to cognitive impairment on a spatial learning task. Proc Natl Acad Sci U S A (1989) 0.99

Genetic evidence for modulation of the activator by two regulatory proteins involved in the exogenous induction of phosphoglycerate transport in Salmonella typhimurium. J Bacteriol (1988) 0.99

Enhanced efficiency of prodrug activation therapy by tumor-selective replicating retrovirus vectors armed with the Escherichia coli purine nucleoside phosphorylase gene. Cancer Gene Ther (2010) 0.98

Immunological properties and conformational differences detected by tritium-hydrogen exchange of clostridial ferredoxins and apoferredoxins. J Biol Chem (1970) 0.98

Detection of two endorphin-like peptides in nucleus caudatus. Neuropharmacology (1978) 0.98

Rat brain enkephalins: distribution and biosynthesis. Adv Biochem Psychopharmacol (1978) 0.97

Vinylglycolate resistance in Escherichia coli. J Bacteriol (1975) 0.96

Electrophysiological and biochemical studies on enhancement of desensitization by phenothiazine neuroleptics. Proc Natl Acad Sci U S A (1983) 0.96

Implications of prolonged expression of Fos-related antigens. Trends Pharmacol Sci (1995) 0.95

Chronic treatment with haloperidol accelerates the biosynthesis of enkephalins in rat striatum. Brain Res (1979) 0.94

[3H]Phencyclidine: a probe for the ionic channel of the nicotinic receptor. Proc Natl Acad Sci U S A (1980) 0.94

Inhibition of neuronal 5-HT uptake by ketamine, but not halothane, involves disruption of substrate recognition by the transporter. Neurosci Lett (1990) 0.94

Selective killing of cholinergic neurons by microglial activation in basal forebrain mixed neuronal/glial cultures. Biochem Biophys Res Commun (1995) 0.94

Selective inhibitors of Candida albicans dihydrofolate reductase: activity and selectivity of 5-(arylthio)-2,4-diaminoquinazolines. J Med Chem (1995) 0.93

Direct homocysteine biosynthesis from O-succinylhomoserine in Escherichia coli: an alternate pathway that bypasses cystathionine. J Bacteriol (1983) 0.92

Volatile anesthetics and glutamate activation of N-methyl-D-aspartate receptors. Biochem Pharmacol (1995) 0.92

The all-or-none mode of the reconstitution and the reactions of a,a'-bipyridyl and mercurials with clostridial ferredoxin. J Biol Chem (1970) 0.92

Alteration of cerebral neurotransmitter receptor function by exposure of rats to manganese. Toxicol Lett (1981) 0.92

Modulation of striatal enkephalinergic neurons by antipsychotic drugs. Fed Proc (1985) 0.92

Time dependency of the action of nitric oxide in lipopolysaccharide-interferon-gamma-induced neuronal cell death in murine primary neuron-glia co-cultures. Brain Res (2000) 0.91

Conversion between configurational states of the muscarinic receptor in rat brain. Eur J Pharmacol (1977) 0.91

Femtomolar concentrations of dynorphins protect rat mesencephalic dopaminergic neurons against inflammatory damage. J Pharmacol Exp Ther (2001) 0.91

Binding of semirigid nicotinic agonists to nicotinic and muscarinic receptors. Mol Pharmacol (1989) 0.91

The nature of the interactions of pyridostigmine with the nicotinic acetylcholine receptor-ionic channel complex. I. Agonist, desensitizing, and binding properties. Mol Pharmacol (1984) 0.90

Structural and stereochemical requirements for muscarinic receptor binding. Mol Pharmacol (1979) 0.90

Sites of action of phencyclidine. I. Effects on the electrical excitability and chemosensitive properties of the neuromuscular junction of skeletal muscle. Mol Pharmacol (1980) 0.90

Similarities in the binding sites of the muscarinic receptor and the ionic channel of the nicotinic receptor. Biochem Pharmacol (1980) 0.90

Neurons reduce glial responses to lipopolysaccharide (LPS) and prevent injury of microglial cells from over-activation by LPS. J Neurochem (2001) 0.90

Nature of regional and chemically-induced differences in the binding properties of muscarinic acetylcholine receptors from rat brain. Neuropharmacology (1980) 0.89

[Met5]Enkephalin content in brain regions of rats treated with lithium. Proc Natl Acad Sci U S A (1978) 0.89

5,8-disubstituted indolizidines: a new class of noncompetitive blockers for nicotinic receptor-channels. Neurochem Res (1991) 0.89

Behavioral and neurochemical effects of orally administered MDMA in the rodent and nonhuman primate. Neurotoxicology (1989) 0.89

Sites of action of phencyclidine. III. Interactions with muscarinic receptors. Mol Pharmacol (1980) 0.89

Changes of hippocampal Met-enkephalin content after recurrent motor seizures. Nature (1980) 0.89

Solubilization of muscarinic acetylcholine receptors of bovine brain. Life Sci (1978) 0.89

Inhibition of lipopolysaccharide-induced nitric oxide and cytokine production by ultralow concentrations of dynorphins in mixed glia cultures. J Pharmacol Exp Ther (1997) 0.88

Role of microglia in inflammation-mediated degeneration of dopaminergic neurons: neuroprotective effect of interleukin 10. J Neural Transm Suppl (2006) 0.88

Phosphorus-31 nuclear magnetic resonance investigation of membrane vesicles from Escherichia coli. Biochemistry (1983) 0.88

Heightened transcription for enzymes involved in norepinephrine biosynthesis in the rat locus coeruleus by immobilization stress. Biol Psychiatry (1999) 0.88

Protein tyrosine kinase inhibitors suppress the production of nitric oxide in mixed glia, microglia-enriched or astrocyte-enriched cultures. Brain Res (1996) 0.87

Clonidine protection from the toxicity of soman, an organophosphate acetylcholinesterase inhibitor, in the mouse. J Pharmacol Exp Ther (1986) 0.87

Cystic fibrosis transmembrane conductance regulator (CFTR) nucleotide-binding domain 1 (NBD-1) and CFTR truncated within NBD-1 target to the epithelial plasma membrane and increase anion permeability. Biochemistry (1998) 0.87

Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, protects dopaminergic neurons from neurotoxin-induced damage. Br J Pharmacol (2012) 0.87

Effect of expression of adenine phosphoribosyltransferase on the in vivo anti-tumor activity of prodrugs activated by E. coli purine nucleoside phosphorylase. Cancer Gene Ther (2011) 0.87

High concentrations of extracellular potassium enhance bacterial endotoxin lipopolysaccharide-induced neurotoxicity in glia-neuron mixed cultures. Neuroscience (2000) 0.87

The effect of kainic acid on the hippocampal content of putative transmitter amino acids. Brain Res (1980) 0.86

Regulation of the metabolism of striatal dynorphin by the dopaminergic system. J Pharmacol Exp Ther (1988) 0.86

Interaction of gephyrotoxin and indolizidine alkaloids with the nicotinic acetylcholine receptor-ion channel complex of Torpedo electroplax. Neurochem Res (1986) 0.86